These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 21395034)
1. [Antiviral therapy in a patient with chronic hepatitis C, metabolic syndrome and interferon-induced depression]. Baĭzhanova ZhZh; Ignatova TM; Kinkul'kina MA Klin Med (Mosk); 2010; 88(6):65-7. PubMed ID: 21395034 [TBL] [Abstract][Full Text] [Related]
2. Interferon-α induced lupus in a patient with chronic hepatitis C virus. Rizvi R; Hojjati M J Clin Rheumatol; 2011 Apr; 17(3):152-3. PubMed ID: 21441813 [No Abstract] [Full Text] [Related]
3. [Combination therapy for chronic viral hepatitis C]. Zeuzem S Dtsch Med Wochenschr; 2003 Feb; 128(8):370-4. PubMed ID: 12594622 [No Abstract] [Full Text] [Related]
4. Thyrotoxic periodic paralysis induced by pegylated interferon alpha plus ribavirin for chronic hepatitis C. Yang WS; Chu PL; Liu CH; Chung GB; Wu KD J Clin Gastroenterol; 2008 Jan; 42(1):112-3. PubMed ID: 18097301 [No Abstract] [Full Text] [Related]
5. Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects. Schaefer M; Hinzpeter A; Mohmand A; Janssen G; Pich M; Schwaiger M; Sarkar R; Friebe A; Heinz A; Kluschke M; Ziemer M; Gutsche J; Weich V; Halangk J; Berg T Hepatology; 2007 Oct; 46(4):991-8. PubMed ID: 17668880 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C. Rogers CJ; Romagosa R; Vincek V J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524 [No Abstract] [Full Text] [Related]
7. Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy. Gordon A; Menahem S; Mitchell J; Jenkins P; Dowling J; Roberts SK Nephrol Dial Transplant; 2004 Aug; 19(8):2155. PubMed ID: 15252182 [No Abstract] [Full Text] [Related]
8. Peginterferon and ribavirin for chronic hepatitis C. Hoofnagle JH; Seeff LB N Engl J Med; 2006 Dec; 355(23):2444-51. PubMed ID: 17151366 [No Abstract] [Full Text] [Related]
9. [Type 1 diabetes developing during alpha-interferon therapy: report of two cases]. Vinagre I; Rigla M; Torras X; Enríquez J; Corcoy R Endocrinol Nutr; 2010 Oct; 57(8):393-5. PubMed ID: 20462813 [No Abstract] [Full Text] [Related]
10. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin. Demirturk N; Aykin N; Demirdal T; Cevik F Eur J Dermatol; 2006; 16(5):579-80. PubMed ID: 17101483 [No Abstract] [Full Text] [Related]
11. Interferon for hepatitis C patients with psychiatric disorders. Asnis GM; De La Garza R; Rego SA; Henderson MA; Reinus JF Am J Psychiatry; 2004 Dec; 161(12):2332; author reply 2332-4. PubMed ID: 15569920 [No Abstract] [Full Text] [Related]
12. [Antiviral therapy of patients with chronic hepatitis C with normal level of aminotransferases]. Lopukhova NL Eksp Klin Gastroenterol; 2007; (4):146-52. PubMed ID: 18409502 [No Abstract] [Full Text] [Related]
13. Interferon for hepatitis C patients with psychiatric disorders. Wilson MS Am J Psychiatry; 2004 Dec; 161(12):2332; author reply 2332-4. PubMed ID: 15569921 [No Abstract] [Full Text] [Related]
14. [Has hepatitis C become curable by a new pegylated interferon?]. Trépo C; Merle P Presse Med; 2001 May; 30(18):905-8. PubMed ID: 11413851 [No Abstract] [Full Text] [Related]